Difference between revisions of "Team:UofC Calgary/Human Practices"
Jegjohnston (Talk | contribs) |
|||
| (63 intermediate revisions by 9 users not shown) | |||
| Line 57: | Line 57: | ||
<div class="c-navbar-wrapper clearfix"> | <div class="c-navbar-wrapper clearfix"> | ||
<div class="c-brand c-pull-left"> | <div class="c-brand c-pull-left"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary | + | <a href="https://2016.igem.org/Team:UofC_Calgary" class="c-logo"> |
<img src="https://static.igem.org/mediawiki/2016/9/9a/Logo-1.png" alt="iGEM" class="c-desktop-logo"> | <img src="https://static.igem.org/mediawiki/2016/9/9a/Logo-1.png" alt="iGEM" class="c-desktop-logo"> | ||
<img src="https://static.igem.org/mediawiki/2016/9/9a/Logo-1.png" alt="iGEM" class="c-desktop-logo-inverse"> | <img src="https://static.igem.org/mediawiki/2016/9/9a/Logo-1.png" alt="iGEM" class="c-desktop-logo-inverse"> | ||
| Line 74: | Line 74: | ||
<nav class="c-mega-menu c-pull-right c-mega-menu-dark c-mega-menu-dark-mobile c-fonts-uppercase c-fonts-bold"> | <nav class="c-mega-menu c-pull-right c-mega-menu-dark c-mega-menu-dark-mobile c-fonts-uppercase c-fonts-bold"> | ||
<!-- BEGIN: MEGA MENU --> | <!-- BEGIN: MEGA MENU --> | ||
| − | + | <ul class="nav navbar-nav c-theme-nav"> | |
<li class="c-menu-type-classic"> | <li class="c-menu-type-classic"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary | + | <a href="https://2016.igem.org/Team:UofC_Calgary" class="c-link dropdown-toggle">Home</a> |
</li> | </li> | ||
<li class="c-menu-type-classic"> | <li class="c-menu-type-classic"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Description" class="c-link dropdown-toggle">Project</a> |
<ul class="dropdown-menu c-menu-type-inline c-pull-left"> | <ul class="dropdown-menu c-menu-type-inline c-pull-left"> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Description">Problem</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Experiments">Our Experiments</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Results">Our Results</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Model">Model</a> |
| + | </li><li> | ||
| + | <a href="https://2016.igem.org/Team:UofC_Calgary/Design">Applied Design</a> | ||
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Parts">Parts Registry</a> |
</li> | </li> | ||
| + | <li> | ||
| + | <a href="https://2016.igem.org/Team:UofC_Calgary/Composite_Part">Composite Parts</a> | ||
| + | </li> | ||
| + | |||
</ul> | </ul> | ||
</li> | </li> | ||
<li class="c-menu-type-classic"> | <li class="c-menu-type-classic"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Judging" class="c-link">Judging</a> |
</li> | </li> | ||
<li class="c-active c-menu-type-classic"> | <li class="c-active c-menu-type-classic"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Human_Practices" class="c-link dropdown-toggle">Human Practices</a> |
<ul class="dropdown-menu c-menu-type-inline c-pull-left"> | <ul class="dropdown-menu c-menu-type-inline c-pull-left"> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/Integrated_Practices | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Integrated_Practices">Integrated Practices</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations">Collaborations</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/Engagement | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Engagement">Engagement</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/Safety | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Safety">Safety</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/HP/Silver | + | <a href="https://2016.igem.org/Team:UofC_Calgary/HP/Silver">Silver</a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/HP/Gold | + | <a href="https://2016.igem.org/Team:UofC_Calgary/HP/Gold">Gold</a> |
</li> | </li> | ||
| + | <li> | ||
| + | <a href="https://2016.igem.org/Team:UofC_Calgary/Policy"> Policy Brief </a> | ||
| + | </li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
<li class="c-menu-type-classic"> | <li class="c-menu-type-classic"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Notebook" class="c-link">Notebook</a> |
</li> | </li> | ||
<li class="c-menu-type-classic"> | <li class="c-menu-type-classic"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Team" class="c-link dropdown-toggle">Team</a> |
<ul class="dropdown-menu c-menu-type-inline c-pull-left"> | <ul class="dropdown-menu c-menu-type-inline c-pull-left"> | ||
<li> | <li> | ||
| − | <a href="Team">Meet Our Team | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Team">Meet Our Team</a> |
| − | + | ||
| − | + | ||
| − | + | ||
</li> | </li> | ||
<li> | <li> | ||
| − | <a href=" | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Attributions">Attributions</a> |
</li> | </li> | ||
| Line 145: | Line 151: | ||
<li> | <li> | ||
| − | <a href="https://2016.igem.org/Main_Page" data-toggle="modal" data-target="#login-form" class="c-btn-border-opacity-04 c-btn btn-no-focus c-btn-header btn btn-sm c-btn-border-1x c-btn-white c-btn-circle | + | <a href="https://2016.igem.org/Main_Page" data-toggle="modal" data-target="#login-form" class="c-btn-border-opacity-04 c-btn btn-no-focus c-btn-header btn btn-sm c-btn-border-1x c-btn-white c-btn-circle c-btn-sbold"><i class="icon-chemistry"></i> iGEM </a> |
</li> | </li> | ||
<li class="c-quick-sidebar-toggler-wrapper"> | <li class="c-quick-sidebar-toggler-wrapper"> | ||
| Line 238: | Line 244: | ||
<div class="row-fluid"> | <div class="row-fluid"> | ||
<div class="span12"> | <div class="span12"> | ||
| − | <div style="position: relative | + | <div style="position: relative;"> |
<a id="img-scroll1"> | <a id="img-scroll1"> | ||
| Line 272: | Line 278: | ||
<div class="col-sm-8 col-sm-offset-2"> | <div class="col-sm-8 col-sm-offset-2"> | ||
<p class="human-practices-div-2"> | <p class="human-practices-div-2"> | ||
| − | For any new scientific creation, it is important to imagine how the project will impact existing political, economic, and societal frameworks. This is particularly important for projects that can have far-reaching consequences, such as ones involving cells in | + | For any new scientific creation, it is important to imagine how the project will impact existing political, economic, and societal frameworks. This is particularly important for projects that can have far-reaching consequences, such as ones involving cells in a therapeutic product, or products with novel applications such as space travel.</p> |
| − | <p class="human-practices-div-2">When designing our product, we had many questions of how we can optimize the design to best address the numerous political, manufacturing, economic, as well as end user experience aspects of our product lifecycle. In order to get answers to these questions, our human practices team did | + | <p class="human-practices-div-2">When designing our product, we had many questions of how we can optimize the design to best address the numerous political, manufacturing, economic, as well as end user experience aspects of our product throughout its lifecycle. In order to get answers to these questions, our human practices team did extensive research, as well as conducted numerous interviews with professionals working in related fields. See all the professionals that we have spoken to in order to improve our project design on our |
| − | <p class="human-practices-div-2">We've incorporated all of the comments we've obtained from professionals into the design of our product. See how all the feedback has informed our project design on our HP | + | <a href="https://2016.igem.org/Team:UofC_Calgary/HP/Silver" style="font-color:red">Human Practices Silver Medal</a> page.</p> |
| − | <p class="human-practices-div-2">See our human practices highlights on our | + | <p class="human-practices-div-2">We've incorporated all of the comments we've obtained from professionals into the design of our product. See how all the feedback has informed our project design on our <a href="https://2016.igem.org/Team:UofC_Calgary/HP/Gold">Human Practices Gold Medal</a> page.</p> |
| − | <p class="human-practices-div-2">As part of integration of human practices into our project, we've also considered the process it would take for our drug to go from the lab bench to the market. To such ends, we decided to reach out to Dr. Agnes Klein, who is currently the | + | <p class="human-practices-div-2">See our human practices highlights on our <a href="https://2016.igem.org/Team:UofC_Calgary/Integrated_Practices">Integrated Human Practices</a> page.</p> |
| + | <p class="human-practices-div-2">As part of integration of human practices into our project, we've also considered the process it would take for our drug to go from the lab bench to the market. To such ends, we decided to reach out to Dr. Agnes Klein, who is currently the Director of the Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada.</p> | ||
<p class="human-practices-div-2">During our conversation, Dr. Klein made aware to us that there are currently no specific regulations in Canada pertaining to the development and marketization of synbio products. Having specific regulations would be beneficial for both prevention of adverse events as well as streamline the process of synbio drug approval. </p> | <p class="human-practices-div-2">During our conversation, Dr. Klein made aware to us that there are currently no specific regulations in Canada pertaining to the development and marketization of synbio products. Having specific regulations would be beneficial for both prevention of adverse events as well as streamline the process of synbio drug approval. </p> | ||
<p class="human-practices-div-2">We decided to address this gap in current Canadian regulations by writing a policy brief. </p> | <p class="human-practices-div-2">We decided to address this gap in current Canadian regulations by writing a policy brief. </p> | ||
| Line 293: | Line 300: | ||
<div class="row"> | <div class="row"> | ||
<div class="col-sm-3" style="padding-left:40px"> | <div class="col-sm-3" style="padding-left:40px"> | ||
| − | <img class="box-img" src="https://static.igem.org/mediawiki/2016/3/3e/T--UofC_Calgary--letstalk.png"> </img> | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Engagement#LTS"> |
| + | <img class="box-img" src="https://static.igem.org/mediawiki/2016/3/3e/T--UofC_Calgary--letstalk.png"> </img> </a> | ||
</div> | </div> | ||
<div class="col-sm-3" style="padding-left:28px; padding-right:28px"> | <div class="col-sm-3" style="padding-left:28px; padding-right:28px"> | ||
| − | <img class="box-img" src="https://static.igem.org/mediawiki/2016/8/8f/T--UofC_Calgary--telusspark.png"> </img> | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Engagement#TS"> |
| + | <img class="box-img" src="https://static.igem.org/mediawiki/2016/8/8f/T--UofC_Calgary--telusspark.png"> </img> </a> | ||
</div> | </div> | ||
<div class="col-sm-3" style="padding-right:40px"> | <div class="col-sm-3" style="padding-right:40px"> | ||
| − | <img class="box-img" src="https://static.igem.org/mediawiki/2016/6/61/T--UofC_Calgary--mindsin.png"> </img> | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Engagement#MIM"> |
| + | <img class="box-img" src="https://static.igem.org/mediawiki/2016/6/61/T--UofC_Calgary--mindsin.png"> </img> </a> | ||
</div> | </div> | ||
<div class="col-sm-3" style="padding-right:40px"> | <div class="col-sm-3" style="padding-right:40px"> | ||
| − | <img class="box-img" src="https://static.igem.org/mediawiki/2016/7/70/T--UofC_Calgary--Beakernight.png"> </img> | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Engagement#BN"> |
| + | <img class="box-img" src="https://static.igem.org/mediawiki/2016/7/70/T--UofC_Calgary--Beakernight.png"> </img> </a> | ||
</div> | </div> | ||
</div> <span id="third" /> | </div> <span id="third" /> | ||
| − | <div class="col-sm-12 human-practices-div-4" style="padding-top: 25px; padding-bottom: 25px; color: #EBDEBE; | + | <div class="col-sm-12 human-practices-div-4" style="padding-top: 25px; padding-bottom: 25px; color: #EBDEBE;"> Click to learn more about our engagement events. </div> |
</div> | </div> | ||
</div> | </div> | ||
| Line 311: | Line 322: | ||
<div class="c-content-box c-size-md" style="background-color: #EBC775; padding-bottom: 0px;"> | <div class="c-content-box c-size-md" style="background-color: #EBC775; padding-bottom: 0px;"> | ||
<div class="container"> | <div class="container"> | ||
| − | + | <div class="c-content-title-1"> | |
| − | + | <h3 class="c-center c-font-uppercase c-font-bold" style="color:#223237" >Collaboration</h3> | |
<div class="c-line-center c-theme-bg"> | <div class="c-line-center c-theme-bg"> | ||
</div> | </div> | ||
| Line 319: | Line 330: | ||
<div class="col-sm-8 col-sm-offset-2" style="background-color: #223237;"> | <div class="col-sm-8 col-sm-offset-2" style="background-color: #223237;"> | ||
<div class="row"> | <div class="row"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations"> |
| − | <div class="col-sm- | + | <div class="col-sm-11 col-sm-offset-0.5"> |
| − | <p class="c-font-white c-fonts-bold" style="font-size: 3em"> | + | <p class="c-font-white c-fonts-bold" style="font-size: 3em">Guanajuato Mexico (GTO_Mexico)</p> |
| − | <p class="c-font-white c-fonts-bold" style="font-size: | + | <p class="c-font-white c-fonts-bold" style="font-size: 2"> We collaborated with the Guanajuato Mexico team in developing a curriculum as an introduction to synthetic biology for university students. This curriculum covered the basics of biology, synthetic biology and applications. Specifically, we designed a lesson plan on the ethics of synthetic biology followed by a debate on the justification of using synthetic biology in a real case study.</p> |
</div></a> | </div></a> | ||
</div> | </div> | ||
| Line 330: | Line 341: | ||
<div class="col-sm-8 col-sm-offset-2" style="background-color: #223237;"> | <div class="col-sm-8 col-sm-offset-2" style="background-color: #223237;"> | ||
<div class="row"> | <div class="row"> | ||
| − | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations/ | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations"> |
| − | <div class="col-sm- | + | <div class="col-sm-11 col-sm-offset-0.5"> |
| − | <p class="c-font-white c-fonts-bold" style="font-size: 3em"> | + | <p class="c-font-white c-fonts-bold" style="font-size: 3em"> Rice University </p> |
| − | <p class="c-font-white c-fonts-bold" style="font-size: | + | <p class="c-font-white c-fonts-bold" style="font-size: 2"> We contributed to the Humans of Syn Bio Project by adding stories from members of our team about how they became involved with iGEM. </p> |
| + | </div> | ||
| + | </a> | ||
| + | </div> | ||
| + | </div> | ||
| + | </div> | ||
| + | <div style="padding-top: 3em" class="row"> | ||
| + | <div class="col-sm-8 col-sm-offset-2" style="background-color: #223237;"> | ||
| + | <div class="row"> | ||
| + | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations"> | ||
| + | <div class="col-sm-11 col-sm-offset-0.5"> | ||
| + | <p class="c-font-white c-fonts-bold" style="font-size: 3em"> UrbanTundra_Edmonton</p> | ||
| + | <p class="c-font-white c-fonts-bold" style="font-size: 2"> This year the UrbanTunda_Edmonton team also worked on a space-related project. They developed an automated prototype for ClO<sub>4</sub> extraction, its conversion to rocket fuel, and its genetically engineered biodegradation to oxygen. We helped the high school team by connecting them with our contacts within the Canadian Space Agency to answer some of their questions.</p> | ||
| + | </div> | ||
| + | </a> | ||
| + | </div> | ||
| + | </div> | ||
| + | </div> | ||
| + | <div style="padding-top: 3em" class="row"> | ||
| + | <div class="col-sm-8 col-sm-offset-2" style="background-color: #223237;"> | ||
| + | <div class="row"> | ||
| + | <a href="https://2016.igem.org/Team:UofC_Calgary/Collaborations"> | ||
| + | <div class="col-sm-11 col-sm-offset-0.5"> | ||
| + | <p class="c-font-white c-fonts-bold" style="font-size: 3em"> MindFuel & aGEM </p> | ||
| + | <p class="c-font-white c-fonts-bold" style="font-size: 2"> We hosted and helped organize the Alberta iGEM (aGEM) competition in collaboration with MindFuel and GeekStarter. This competition helped to prepare the Alberta teams for the international iGEM competition by mimicking the presentation layout expected at Jamboree and meeting with well-known iGEM judges such as Megan Palmer and Todd Kuiken.</p> | ||
</div> | </div> | ||
</a> | </a> | ||
| Line 341: | Line 376: | ||
</div> | </div> | ||
<span id="fourth"/> | <span id="fourth"/> | ||
| − | <div class="human-practices-div-4" style="padding-top: 25px; padding-bottom: 25px; color: #223237;"> Click to learn more about | + | <div class="human-practices-div-4" style="padding-top: 25px; padding-bottom: 25px; color: #223237;"> Click to learn more about our collaborations. </div> |
</div> | </div> | ||
</div> | </div> | ||
| − | + | <a href="https://2016.igem.org/Team:UofC_Calgary/Safety"> | |
<div class="c-content-box c-size-md" style="background-color: #172724"> | <div class="c-content-box c-size-md" style="background-color: #172724"> | ||
<div class="container"> | <div class="container"> | ||
| Line 354: | Line 389: | ||
<div class="row"> | <div class="row"> | ||
<div class="col-sm-8 col-sm-offset-2"> | <div class="col-sm-8 col-sm-offset-2"> | ||
| − | <p class="human-practices-div-2"> | + | <p class="human-practices-div-2" style="color: #FFFFFF"> |
| − | Safety is very important to any product of science | + | Safety is very important to any product of science; as such, we take safety very seriously in our lab. See our safety practices as well as the safety considerations for our project on our <a href="https://2016.igem.org/Team:UofC_Calgary/Safety">Safety page.</a> |
</p> | </p> | ||
</div> | </div> | ||
| Line 361: | Line 396: | ||
</div> | </div> | ||
</div> | </div> | ||
| + | </a> | ||
<!-- END: CONTENT/MISC/ABOUT-1 --> | <!-- END: CONTENT/MISC/ABOUT-1 --> | ||
| Line 375: | Line 411: | ||
<div class="c-container c-first"> | <div class="c-container c-first"> | ||
<div class="c-content-title-1"> | <div class="c-content-title-1"> | ||
| − | <h3 class=" | + | <h3 class="c-font-bold c-font-white">i<span class="c-theme-font">GEM</span></h3> |
<div class="c-line-left hide"> | <div class="c-line-left hide"> | ||
</div> | </div> | ||
<p class="c-text"> | <p class="c-text"> | ||
| − | + | iGEM is an international competition promoting synthetic biology as a means to solve social, economic and humanitarian problems around the globe. The iGEM Jamboree is held in Boston annually. In 2016, over 300 teams are competing against each other. | |
</p> | </p> | ||
</div> | </div> | ||
<ul class="c-links"> | <ul class="c-links"> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</ul> | </ul> | ||
</div> | </div> | ||
| Line 407: | Line 432: | ||
<div class="c-blog"> | <div class="c-blog"> | ||
<div class="c-post"> | <div class="c-post"> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</div> | </div> | ||
<div class="c-post c-last"> | <div class="c-post c-last"> | ||
<div class="c-post-img"> | <div class="c-post-img"> | ||
| − | <img src=" | + | <img src="https://static.igem.org/mediawiki/2016/d/dc/T--UofC_Calgary--WHMIS.jpg" alt="" class="img-responsive"/> |
</div> | </div> | ||
<div class="c-post-content"> | <div class="c-post-content"> | ||
<h4 class="c-post-title"><a href="#">Fully Trained!</a></h4> | <h4 class="c-post-title"><a href="#">Fully Trained!</a></h4> | ||
<p class="c-text"> | <p class="c-text"> | ||
| − | + | Our entire team received a full BioSafety education from the University of Calgary! This entailed going to classes to prepare for a final quiz that tested our ability to be safe in the lab. Several of our members also had radiation training and clearance to ensure that work done with radiation was safe! | |
</p> | </p> | ||
</div> | </div> | ||
| Line 492: | Line 509: | ||
<a href="https://twitter.com/igemcalgary"><i class="icon-social-twitter"></i></a> | <a href="https://twitter.com/igemcalgary"><i class="icon-social-twitter"></i></a> | ||
</li> | </li> | ||
| + | |||
<li> | <li> | ||
| − | + | <a href="http://www.instagram.com/igemcalgary"><i class="icon-camera"></i></a> | |
| − | + | ||
| − | + | ||
| − | <a href="http://www.instagram.com/igemcalgary"><i class="icon- | + | |
</li> | </li> | ||
</ul> | </ul> | ||
| Line 504: | Line 519: | ||
</li> | </li> | ||
<li> | <li> | ||
| − | + | <i class="icon-envelope c-theme-font"></i> igem.calgary@gmail.com | |
| − | + | ||
| − | + | ||
| − | <i class="icon-envelope c-theme-font"></i> | + | |
</li> | </li> | ||
</ul> | </ul> | ||
Latest revision as of 23:10, 19 October 2016
Policies and Practices
For any new scientific creation, it is important to imagine how the project will impact existing political, economic, and societal frameworks. This is particularly important for projects that can have far-reaching consequences, such as ones involving cells in a therapeutic product, or products with novel applications such as space travel.
When designing our product, we had many questions of how we can optimize the design to best address the numerous political, manufacturing, economic, as well as end user experience aspects of our product throughout its lifecycle. In order to get answers to these questions, our human practices team did extensive research, as well as conducted numerous interviews with professionals working in related fields. See all the professionals that we have spoken to in order to improve our project design on our Human Practices Silver Medal page.
We've incorporated all of the comments we've obtained from professionals into the design of our product. See how all the feedback has informed our project design on our Human Practices Gold Medal page.
See our human practices highlights on our Integrated Human Practices page.
As part of integration of human practices into our project, we've also considered the process it would take for our drug to go from the lab bench to the market. To such ends, we decided to reach out to Dr. Agnes Klein, who is currently the Director of the Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada.
During our conversation, Dr. Klein made aware to us that there are currently no specific regulations in Canada pertaining to the development and marketization of synbio products. Having specific regulations would be beneficial for both prevention of adverse events as well as streamline the process of synbio drug approval.
We decided to address this gap in current Canadian regulations by writing a policy brief.
Engagement
Click to learn more about our engagement events.
Collaboration
Click to learn more about our collaborations.
Safety
Safety is very important to any product of science; as such, we take safety very seriously in our lab. See our safety practices as well as the safety considerations for our project on our Safety page.
